303 related articles for article (PubMed ID: 19269032)
1. Impact of methionine oxidation on the binding of human IgG1 to Fc Rn and Fc gamma receptors.
Bertolotti-Ciarlet A; Wang W; Lownes R; Pristatsky P; Fang Y; McKelvey T; Li Y; Li Y; Drummond J; Prueksaritanont T; Vlasak J
Mol Immunol; 2009 May; 46(8-9):1878-82. PubMed ID: 19269032
[TBL] [Abstract][Full Text] [Related]
2. Impact of methionine oxidation in human IgG1 Fc on serum half-life of monoclonal antibodies.
Wang W; Vlasak J; Li Y; Pristatsky P; Fang Y; Pittman T; Roman J; Wang Y; Prueksaritanont T; Ionescu R
Mol Immunol; 2011 Mar; 48(6-7):860-6. PubMed ID: 21256596
[TBL] [Abstract][Full Text] [Related]
3. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.
Kanda Y; Yamada T; Mori K; Okazaki A; Inoue M; Kitajima-Miyama K; Kuni-Kamochi R; Nakano R; Yano K; Kakita S; Shitara K; Satoh M
Glycobiology; 2007 Jan; 17(1):104-18. PubMed ID: 17012310
[TBL] [Abstract][Full Text] [Related]
4. A novel approach to investigate the effect of methionine oxidation on pharmacokinetic properties of therapeutic antibodies.
Stracke J; Emrich T; Rueger P; Schlothauer T; Kling L; Knaupp A; Hertenberger H; Wolfert A; Spick C; Lau W; Drabner G; Reiff U; Koll H; Papadimitriou A
MAbs; 2014; 6(5):1229-42. PubMed ID: 25517308
[TBL] [Abstract][Full Text] [Related]
5. Field flow fractionation for assessing neonatal Fc receptor and Fcγ receptor binding to monoclonal antibodies in solution.
Pollastrini J; Dillon TM; Bondarenko P; Chou RY
Anal Biochem; 2011 Jul; 414(1):88-98. PubMed ID: 21385563
[TBL] [Abstract][Full Text] [Related]
6. Effect of individual Fc methionine oxidation on FcRn binding: Met252 oxidation impairs FcRn binding more profoundly than Met428 oxidation.
Gao X; Ji JA; Veeravalli K; Wang YJ; Zhang T; Mcgreevy W; Zheng K; Kelley RF; Laird MW; Liu J; Cromwell M
J Pharm Sci; 2015 Feb; 104(2):368-77. PubMed ID: 25175600
[TBL] [Abstract][Full Text] [Related]
7. Affinity of the interaction between Fc gamma receptor type III (Fc gammaRIII) and monomeric human IgG subclasses. Role of Fc gammaRIII glycosylation.
Galon J; Robertson MW; Galinha A; Mazières N; Spagnoli R; Fridman WH; Sautès C
Eur J Immunol; 1997 Aug; 27(8):1928-32. PubMed ID: 9295028
[TBL] [Abstract][Full Text] [Related]
8. Structure and stability changes of human IgG1 Fc as a consequence of methionine oxidation.
Liu D; Ren D; Huang H; Dankberg J; Rosenfeld R; Cocco MJ; Li L; Brems DN; Remmele RL
Biochemistry; 2008 May; 47(18):5088-100. PubMed ID: 18407665
[TBL] [Abstract][Full Text] [Related]
9. Humanized IgG1 variants with differential binding properties to the neonatal Fc receptor: relationship to pharmacokinetics in mice and primates.
Datta-Mannan A; Witcher DR; Tang Y; Watkins J; Jiang W; Wroblewski VJ
Drug Metab Dispos; 2007 Jan; 35(1):86-94. PubMed ID: 17050651
[TBL] [Abstract][Full Text] [Related]
10. Understanding the Impact of Methionine Oxidation on the Biological Functions of IgG1 Antibodies Using Hydrogen/Deuterium Exchange Mass Spectrometry.
Mo J; Yan Q; So CK; Soden T; Lewis MJ; Hu P
Anal Chem; 2016 Oct; 88(19):9495-9502. PubMed ID: 27575380
[TBL] [Abstract][Full Text] [Related]
11. Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity.
Kumpel BM; Rademacher TW; Rook GA; Williams PJ; Wilson IB
Hum Antibodies Hybridomas; 1994; 5(3-4):143-51. PubMed ID: 7756579
[TBL] [Abstract][Full Text] [Related]
12. Functional assessment of antibody oxidation by native mass spectrometry.
Haberger M; Heidenreich AK; Schlothauer T; Hook M; Gassner J; Bomans K; Yegres M; Zwick A; Zimmermann B; Wegele H; Bonnington L; Reusch D; Bulau P
MAbs; 2015; 7(5):891-900. PubMed ID: 26000623
[TBL] [Abstract][Full Text] [Related]
13. The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex.
Sondermann P; Huber R; Oosthuizen V; Jacob U
Nature; 2000 Jul; 406(6793):267-73. PubMed ID: 10917521
[TBL] [Abstract][Full Text] [Related]
14. Effect of methionine oxidation of a recombinant monoclonal antibody on the binding affinity to protein A and protein G.
Gaza-Bulseco G; Faldu S; Hurkmans K; Chumsae C; Liu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(1):55-62. PubMed ID: 18567545
[TBL] [Abstract][Full Text] [Related]
15. Integrin binding human antibody constant domains--probing the C-terminal structural loops for grafting the RGD motif.
Traxlmayr MW; Wozniak-Knopp G; Antes B; Stadlmayr G; Rüker F; Obinger C
J Biotechnol; 2011 Sep; 155(2):193-202. PubMed ID: 21771617
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies with identical Fc sequences can bind to FcRn differentially with pharmacokinetic consequences.
Wang W; Lu P; Fang Y; Hamuro L; Pittman T; Carr B; Hochman J; Prueksaritanont T
Drug Metab Dispos; 2011 Sep; 39(9):1469-77. PubMed ID: 21610128
[TBL] [Abstract][Full Text] [Related]
17. Lipocortin 1 binding to human leukocytes correlates with its ability to inhibit IgG interactions with Fc gamma receptors.
Goulding NJ; Guyre PM
Biochem Biophys Res Commun; 1993 Apr; 192(2):351-8. PubMed ID: 8484747
[TBL] [Abstract][Full Text] [Related]
18. Oxidation of M252 but not M428 in hu-IgG1 is responsible for decreased binding to and activation of hu-FcγRIIa (His131).
Cymer F; Thomann M; Wegele H; Avenal C; Schlothauer T; Gygax D; Beck H
Biologicals; 2017 Nov; 50():125-128. PubMed ID: 28988621
[TBL] [Abstract][Full Text] [Related]
19. Reduced elimination of IgG antibodies by engineering the variable region.
Igawa T; Tsunoda H; Tachibana T; Maeda A; Mimoto F; Moriyama C; Nanami M; Sekimori Y; Nabuchi Y; Aso Y; Hattori K
Protein Eng Des Sel; 2010 May; 23(5):385-92. PubMed ID: 20159773
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of the human leukocyte Fc receptor, Fc gammaRIIa.
Maxwell KF; Powell MS; Hulett MD; Barton PA; McKenzie IF; Garrett TP; Hogarth PM
Nat Struct Biol; 1999 May; 6(5):437-42. PubMed ID: 10331870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
